tbuckley/cabot-search huggingface dataset:
Comparison of Mismatch Repair Status Between Primary and Matched Metastatic Sites in Patients With Colorectal Cancer
Authors: Wen-Zhuo He, Wan-Ming Hu, Fang Wang, Yu-Ming Rong, Lin Yang, Qian-Kun Xie, Yuan-Zhong Yang, Chang Jiang, Hui-Juan Qiu, Jia-Bin Lu, Bei Zhang, Pei-Rong Ding, Xiao-Jun Xia, Jian-Yong Shao, Liang-Ping Xia
Journal: Journal of the National Comprehensive Cancer Network (2019)

Differences between the features of primary cancer and matched metastatic cancer have recently drawn attention in research. This study investigated the concordance in microsatellite instability (MSI) and mismatch repair (MMR) status between primary and corresponding metastatic colorectal cancer (CRC).Consecutive patients with metastatic CRC who had both primary and metastatic tumors diagnosed at our institution in January 2008 through December 2016 were identified. Immunohistochemistry was used to test the MMR status of both primary and matched metastatic tumors, and PCR analysis was performed to test MSI in patients with deficient MMR (dMMR) status.A total of 369 patients were included. Of the 46 patients with MSI-high primary tumors, 37 (80.4%) also had MSI-high metastatic tumors, whereas 9 (19.6%) had microsatellite stable (MSS) metastatic tumors. A high concordance was found in patients with liver, lung, or distant lymph node metastases. Interestingly, the discrepancy was more likely to be limited to peritoneal (5/20) or ovarian (4/4) metastasis (chi-square test, P<.001). These organ-specific features were also found in the pooled analysis. Along with the change of MSI-high in primary cancer to MSS in metastatic cancer, lymphocyte infiltration decreased significantly (P=.008). However, the change did not influence survival; the median overall survival of MSI-high and MSS metastatic tumors was 21.3 and 21.6 months, respectively (P=.774). The discrepancy rate was 1.6% for patients with proficient MMR primary tumors.For patients with dMMR primary tumors, the concordance of MSI and MMR status in primary CRC and corresponding metastatic cancer is potentially organ-specific. High concordance is found in liver, lung, and distant lymph node metastases, whereas discrepancy is more likely to occur in peritoneal or ovarian metastasis. Rebiopsy to evaluate MSI-high/dMMR status might be needed during the course of anti-PD-1 therapy in cases of peritoneal or ovarian metastasis.
Integrative Analysis of Ikaros-Dependent Changes of Transcriptional Regulation and Tyrosine Phosphorylation Events in Ph+ ALL
Authors: Huimin Geng, Rahul Nahar, Parham Ramezani-Rad, Zhengshan Chen, Jeffrey W. Tyner, Bill H. Chang, Bjorn Titz, Maike Buchner, Christian Hurtz, Thomas G. Graeber, Brian J. Druker, Elisabeth Paietta, Ari Melnick, Cheryl L. Willman, William L. Carroll, Markus Muschen
Journal: Blood (2012)
ATM Gene Point Mutation and Frameshift Mutation Are Found In High-Risk, Untreated Chronic Lymphocytic Leukemia Patients with Interstitial Deletion of Chromosome 11q and Uniparental Disomy of Chromosome 11q
Authors: Steven A. Schichman, Jennifer H. Han, Juan-Sebastian Saldivar, Annjanette Stone, Maria Winters, Weleetka Carter, Lori Frederick, David S. Viswanatha, Clive S. Zent
Journal: Blood (2010)
In Elderly Patients with CML Second Generation TKIs Are Very Effective and Can be Given Long Term Particularly in the Absence of Comorbidities: A Single Center Experience
Authors: Mariella D'Adda, Elisa Cerqui, Samantha Ferrari, Chiara Bottelli, Angela Passi, Francesca Schieppati, Rosaria Scaduto, Giuseppe Rossi
Journal: Blood (2016)
Blocking TRAF6 Function Domain by TRAF6 Dominant Negative (TRAF6dn) for Inhibition of Multiple Myeloma Cell Proliferative and Increase of Apoptosis through Regulation of NF-κB and JNK Pathways.
Authors: Haiming Chen, Mingjie Li, Richard A. Campbell, Melinda S. Gordon, Dror Shalitin, Cathy S. Wang, Ariana M. Berenson, Jennifer Li, Charles B. Drucker, Benjamin Bonavida, James R. Berenson
Journal: Blood (2006)
Prognostic Effect of Bone Marrow (BM) and Peripheral Blood Stem Cell (PBSC) Donor Cell Subsets on Myeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes
Authors: Sagar S. Patel, Lisa Rybicki, Donna Abounader, Carol Dumont, Brian J. Bolwell, Robert Dean, Priscilla Figueroa, Rabi Hanna, Hien K. Liu, Aaron T. Gerds, Brian T. Hill, Deepa Jagadeesh, Matt Kalaycio, Kristin Ricci, Ronald Sobecks, Betty K. Hamilton, Navneet S. Majhail
Journal: Blood (2016)
Efficacy of Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
Authors: Shannon L Maude, David M. Barrett, Susan R. Rheingold, Richard Aplenc, David T Teachey, Colleen Callahan, Diane Baniewicz, Claire White, Mala K. Talekar, Pamela A Shaw, Jennifer L Brogdon, Regina M Young, John Scholler, Katherine T. Marcucci, Bruce L Levine, Noelle Frey, David L Porter, Simon F. Lacey, J. Joseph Melenhorst, Carl H June, Stephan A. Grupp
Journal: Blood (2016)
The Prolyl-3-Hydroxylase Leprecan Like 1 (Leprel1) Is a Selective Target for Epigenetic Silencing In Multiple Myeloma.
Authors: Eleftheria Hatzimichael, Evangelia Xirofotou, Aggeliki Dasoula, Cristiana Lo Nigro, Laura Lattanzio, Marco Merlano, George Dranitsaris, Konstantinos Bourantas, Tim Crook
Journal: Blood (2010)
A Multicenter Phase I Study of CTLA-4 Blockade with Ipilimumab for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation
Authors: Matthew S. Davids, Haesook T. Kim, Caitlin L. Costello, David Avigan, Yi-Bin Chen, Philippe Armand, Edwin P. Alyea, Jacquelyn Hedlund, Peter A. McSweeney, Rebecca Liguori, Jerome Ritz, Edward D. Ball, Asad Bashey, Robert J Soiffer
Journal: Blood (2014)
Gemcitabine-Based Salvage Chemotherapy as a Bridge to Allogeneic Hematopoietic Stem Cell Transplantation for the Patients with Relapse of Hodgkin Lymphoma After Autologous Hematopoietic Stem Cell Transplantation.
Authors: Anna Czyz, Adam Nowicki, Lidia Gil, Dominik Dytfeld, Anna Lojko-Dankowska, Jan Styczynski, Mieczyslaw Komarnicki
Journal: Blood (2010)
Busulfan/Fludarabine/Thymoglobulin as a Reduced Intensity Conditioning Regimen for Lymphoid Malignancies.
Authors: Jeevan Sekhar, Keith Stockerl-Goldstein, Qin Zhang, Amanda F Cashen, Camille N. Abboud, Geoffrey L. Uy, Peter Westervelt, John F. DiPersio, Ravi Vij
Journal: Blood (2009)
Dynamics of Minimal Residual Leukemia After Combinations of the HyperCVAD Regimen with Imatinib or Dasatinib In Patients with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia
Authors: Farhad Ravandi, Deborah A Thomas, Susan O'Brien, Stefan Faderl, Jeffrey Jorgensen, Rajyalakshmi Luthra, Dan Jones, Rebecca Garris, Jorge E. Cortes, Hagop Kantarjian
Journal: Blood (2010)
The First Human Cell Line Recombinant Factor VIII (Human-cl rhFVIII) - Functional Properties and Differences From Currently Available Recombinant Factor VIII Products.
Authors: Bruce A. Schwartz, Helena Sandberg, Irene Agerkvist, Christoph Kannicht, Margareta Ramström, Peter Stenlund, Ulla Oswaldsson, Tobias Brunberg
Journal: Blood (2009)
NOTCH1 Mutated IGHV Unmutated Chronic Lymphocytic Leukemia Cells Are Characterized By a Constitutive Overexpression of Nucleophosmin-1 and Ribosome-Associated Components
Authors: Federico Pozzo, Tamara Bittolo, Erika Tissino, Francesca Maria Rossi, Riccardo Bomben, Antonella Zucchetto, Dania Benedetti, Francesca Arruga, Branimir Gizdic, Massimo Degan, Pietro Bulian, Giovanni D'Arena, Francesco Di Raimondo, Francesco Zaja, Gabriele Pozzato, Alberto Zamò, Silvia Deaglio, Davide Rossi, Gianluca Gaidano, Giovanni Del Poeta, Michele Dal Bo, Valter Gattei
Journal: Blood (2014)
Recombinant DEK Enhances Ex Vivo expansion of Human Cord Blood and Mouse Bone Marrow Hematopoietic Stem Cells in a CXCR2- and Hspg-Dependent Manner
Authors: Maegan L. Capitano, Nirit Mor-Vaknin, Maureen Legendre, Scott Cooper, David Markovitz, Hal E. Broxmeyer
Journal: Blood (2015)
Neighborhood Death Rate: A Big-Data Based Health Informatics Pipeline Helps Identify Factors Impacting Clinical Outcomes and Cost Effectiveness in Acute Myeloid Leukemia Patients
Authors: Zheng Yin, Anish S Konde, Mamta Puppala, Pallavi Srivastava, Wong Stephen, Lawrence Rice, Swaminathan Padmanabhan Iyer
Journal: Blood (2014)
Plasmacytoid Dendritic Cell Levels at End of Induction Are Predictive of MRD Clearance and Also Influence Disease Outcome in a Subset of Patients
Authors: Papagudi Ganesan Subramanian, Nikhil Patkar, Prashant Tembhare, Yajamanam Badrinath, Sitaram Ghoghale, Sumeet Gujral, Hari Menon, Hasmukh Jain, Bhausaheb Bagal, Manju Sengar, Navin Khattry
Journal: Blood (2016)
Prognostic Impact of Response According to International Consortium for MDS/MPN Criteria in CMML Treated with Hypomethylating Agents (HMA)
Authors: Matthieu Duchmann, Thorsten Braun, Uwe Platzbecker, Lionel Adès, Marie Sébert, François Dreyfus, Sophie Park, Norbert Vey, Odile Beyne Rauzy, Stéphane De Botton, Jean-Baptiste Micol, Céline Berthon, Romain Guieze, Jean-Noel M. Bastie, Éric Solary, Pierre Fenaux, Raphaël Itzykson
Journal: Blood (2015)
Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): Toxicity and Efficacy Interim Results of the FRALLE 2000-A Protocol.
Authors: Andre Baruchel, Anne Auvrignon, Marie-Françoise Auclerc, Yves Perel, Françoise Mechinaud, Virginie Gandemer, Claudine Schmitt, Geneviève Marguerite, Pascale Schneider, Gérard Michel, Christiane Vermylen, Odile Lejars, Christian Berthou, Claire Berger, Catherine Paillard, Gérard Couillault, Brigitte Pautard, Xavier Rialland, Thierry Leblanc, Guy Leverger
Journal: Blood (2004)
Ang1 Functions as An Autocrine Activating Factor of Tie2 Signaling In Hematopoietic Stem Cells.
Authors: Haruka Momose, Kazuya Takizawa, Madoka Kuramitsu, Takuo Mizukami, Atsuko Masumi, Kazunari Yamaguchi, Isao Hamaguchi
Journal: Blood (2010)
Chromatin Conformation Signatures Associated with Epigenetic Deregulation of the FIP1L1 and PDGFRA Genes
Authors: Francis H Grand, Chloe Bird, Emily Corfield, Mehrnoush Dezfouli, Elvidge Warren, Benjamin Foulkes, Michelle Goloschokin, Nadia Khudari, Matthew Salter, Diana Mahecha, Philip Ssentongo, Jayne Green, Howard Womersley, Ewan Hunter, Aroul Ramadass, Alexandre Akoulitchev
Journal: Blood (2016)
Efficacy and safety of first China-manufactured trastuzumab biosimilar HLX02 for metastatic breast cancer: A phase III trial
Authors: B. Xu, Q. Zhang, T. Sun, W. Li, Y. Teng, X. Hu, I. Bondarenko, H. Adamchuk, L. Zhang, D. Trukhin, B. Li, B. Shan, J. Cheng, T. Peng, W. Jiang, S. Liu, X. Zhang, Q. Wang, E. Liu, A.Y. Luk
Journal: Annals of Oncology (2019)
The IRF2BP2-RARα Fusion Generated By a Cryptic Rearrangement Transforms Hematopoietic Stem/Progenitor Cells and Induces Retinoid Sensitive Acute Promyelocytic Leukemia (APL)
Authors: Jelena V Jovanovic, M Carmen Chillón, Christelle Vincent-Fabert, Richard Dillon, Edwige Voisset, Norma C Gutiérrez, Ellen Solomon, Ramón Garcí­a Sanz, Ana A. Martin Lopez, Yvonne G Morgan, Jennie Lok, Estelle Duprez, Marcos González Díaz, David Grimwade
Journal: Blood (2014)
Inhibition of the RKIP and PTEN-Transcription Repressor Snail in B-NHL by the Proteasome Inhibitor NPI-0052: Roles of RKIP and PTEN Induction in the Reversal of Resistance to TRAIL Apoptosis.
Authors: Stavroula Baritaki, Kam Yeung, Katherine Wu, Haiming Chen, James R. Berenson, Michael A. Palladino, Benjamin Bonavida
Journal: Blood (2009)
Various Gvhd Prophylaxis Regimens Influence Differently T-Memory Cell Subsets Recovery after Allogeneic Stem Cell Transplantation in Leukemia Patients
Authors: Mikhail Drokov, Natalia Popova, Elena Parovichnikova, Larisa Kuzmina, Julia Davydova, Nikolay Kapranov, Ekaterina Mikhaltsova, Olga Koroleva, Vera Vasilyeva, Daria Dubnyak, Zoya Konova, Anna Sidorova, Ekterina Usikova, Anna Dmitrova, Irina V. Galtseva, Mikhail Maschan, Valery G. Savchenko
Journal: Blood (2018)
Outcomes Following Salvage Autologous Stem Cell Transplant for Multiple Myeloma
Authors: Daniel E Fein, Hani Hassoun, Raymond L. Comenzo, Alex Lesokhin, Nikoletta Lendvai, David Chung, Adam Cohen, Michael A. Rosenzweig, Danielle Chimento, Xiaoyu Jia, Stephen Nimer, Sergio Giralt, Heather Landau
Journal: Blood (2010)
The PI3K Specific Inhibitor BKM120 Results Effective and Synergizes With Ruxolitinib In Preclinical Models Of Myeloproliferative Neoplasms
Authors: Niccolò Bartalucci, Costanza Bogani, Serena Martinelli, Carmela Mannarelli, Jean-Luc Villeval, Alessandro M. Vannucchi
Journal: Blood (2013)
C/EBPα, C/EBPα Oncoproteins, or C/EBPβ Preferentially Bind NF-κB p50 Compared with p65 Via Conserved Residues In the C/EBP Basic Region
Authors: Julia E. Dooher, Ido Paz-Priel, Simone Houng, Albert S. Baldwin, Alan D. Friedman
Journal: Blood (2010)
Follicular Lymphoma Tumor Infiltrating T-Helper (Th) Cells Have the Same Intrinsic Polyfunctional Response Potential Upon Stimulation as Do Reactive and Normal Lymph Node Th Cells Despite Having Skewed Differentiation; Implications for Immunotherapy
Authors: Shannon P. Hilchey, Alexander F. Rosenberg, Ollivier Hyrien, Shelley Secor-Socha, Matthew R. Cochran, W. Richard Burack, Jyh-Chiang E. Wang, Sally A. Quataert, Steven H. Bernstein
Journal: Blood (2010)
Biomarkers and clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma in CheckMate 040
Authors: Ignacio Melero, Jaclyn Neely, Bruno Sangro, Richard S. Finn, Ghassan K. Abou-Alfa, Ann-Lii Cheng, Thomas Yau, Junji Furuse, Joong-Won Park, Samir Wadhawan, Hao Tang, Jeffrey Anderson, Zachary Boyd, Ignacio Melero, Anthony El-Khoueiry
Journal: Annals of Oncology (2019)
Renal Outcomes in Patients with AL Amyloidosis: Evaluation of Prognostic Factors and Impact of Therapy with Novel Agents
Authors: Efstathios Kastritis, Maria Roussou, Evangelos Terpos, Maria Gavriatopoulou, Evangelos Eleutherakis-Papaiakovou, Despoina Kalapanida, Sofoklis Kontogiannis, Theofanis Apostolou, Ioannis Boletis, Constantinos Pamboukas, Savvas Th. Toumanidis, Elektra Papadopoulou, Erasmia Psimenou, Meletios A. Dimopoulos
Journal: Blood (2014)
Highly Sensitive and Wearable Liquid Metal‐Based Pressure Sensor for Health Monitoring Applications: Integration of a 3D‐Printed Microbump Array with the Microchannel
Authors: Kyuyoung Kim, Jungrak Choi, Yongrok Jeong, Incheol Cho, Minseong Kim, Seunghwan Kim, Yongsuk Oh, Inkyu Park
Journal: Advanced Healthcare Materials (2019)

Abstract Wearable pressure sensors capable of sensitive, precise, and continuous measurement of physiological and physical signals have great potential for the monitoring of health status and the early diagnosis of diseases. This work introduces a 3D‐printed rigid microbump‐integrated liquid metal‐based soft pressure sensor (3D‐BLiPS) for wearable and health‐monitoring applications. Using a 3D‐printed master mold based on multimaterial fused deposition modeling, the fabrication of a liquid metal microchannel and the integration of a rigid microbump array above the microchannel are achieved in a one‐step, direct process. The microbump array enhances the sensitivity of the pressure sensor (0.158 kPa −1 ) by locally concentrating the deformation of the microchannel with negligible hysteresis and a stable signal response under cyclic loading. The 3D‐BLiPS also demonstrates excellent robustness to 10 000 cycles of multidirectional stretching/bending, changes in temperature, and immersion in water. Finally, these characteristics are suitable for a wide range of applications in health monitoring systems, including a wristband for the continuous monitoring of the epidermal pulse rate for cuffless blood pressure estimation and a wireless wearable device for the monitoring of body pressure using a multiple pressure sensor array for the prevention of pressure ulcers.
Tumor-Derived Microvesicles From Sera of Patients with Acute Myeloid Leukemia Suppresses NK Cell Cytotoxicity Via Transforming Growth Factor Beta-1.
Authors: Miroslaw J Szczepanski, Marta E Szajnik, Malgorzata Czystowska, Magis Mandapathil, Ann Welsh, Theresa L Whiteside, Michael Boyiadzis
Journal: Blood (2009)
A PROGNOSTIC MODEL to PREDICT SURVIVAL In WHO-DEFINED ESSENTIAL THROMBOCYTHEMIA: A STUDY by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
Authors: Francesco Passamonti, Juergen Thiele, Tiziano Barbui, Mario Cazzola, Marco Ruggeri, Francesco Rodeghiero, Marialuigia Randi, Alessandro M. Vannucchi, Heinz Gisslinger, Naseema Gangat, Curtis A Hanson, Elisa Rumi, Emanuela Boveri, Alessandra Carobbio, Andrea Gianatti, Emanuele D'Amore, Irene Bertozzi, Filippo Marino, Margherita Maffioli, Domenica Caramazza, Elisabetta Antonioli, Valentina Carrai, Veronika Buxhofer-Ausch, Bettina Gisslinger, Leonhard Mullauer, Francois Girodon, hans-Michael Kvasnicka, Cristiana Pascutto, Ayalew Tefferi
Journal: Blood (2011)
Interplay Between the Immune System and Colorectal Carcinoma - Towards Tumor-Specific Peptide-Based Vaccination for Any HLA-Type
Authors: Sebastian P. Haen, Daniel Johannes Kowalewski, Stefan Stevanovic, Linus Backert, Florian Dengler, Daniel Backes, Stefan Beckert, Wagner Silvia, Ingmar Koenigsrainer, Hans-Georg Kopp, Oliver Kohlbacher, Alfred Koenigsrainer, Lothar Kanz, Hans-Georg Rammensee, Markus W. Loeffler
Journal: Blood (2015)
Continuous Treatment with Lenalidomide Plus Low-Dose Dexamethasone (Ld) Versus Ld Induction Followed By Autologous Stem Cell Transplant (ASCT) in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Pooled Analysis of Two Randomized Clinical Trials
Authors: Suzanne Lentzsch, Nicolas Villanueva, James Nguyen, Heather Landau, Nikoletta Lendvai, Susanna Miao, Jordan M. Schecter, Mariamne Reyna, Markus Y Mapara, Robert L. Redner, David J Chung, Alexander M. Lesokhin, Tarun Kewalramani, Sergio Giralt, Raymond L. Comenzo, Ola Landgren, Hani Hassoun
Journal: Blood (2015)
Phase I Trial of Prophylactic Rituximab for the Prevention of Post Transplant Epstein-Barr Related Lymphoproliferative Disease (EBV-PTLD) Following T Cell Depleted (TCD) Unrelated or HLA-Mismatched Related Hematopoietic Cell Transplantation (HCT): Efficacy, Toxicity, and Effect on Subsequent B Cell Reconstitution
Authors: Trudy N Small, Nancy A. Kernan, Ann A. Jakubowski, Molly A Knowles, James W Young, Hugo Castro-Malaspina, Susan E Prockop, Richard J. O'Reilly, Esperanza B Papadopoulos
Journal: Blood (2011)
Bortezomib-Based Versus Standard of Care Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation: A Phase II Randomized Controlled Trial
Authors: John Koreth, Haesook T. Kim, Paulina B Lange, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Brett Glotzbecker, Rushdia Z. Yusuf, Sarah Nikiforow, Bimalangshu R. Dey, Malgorzata McMasters, Jerome Ritz, Bruce R. Blazar, Robert J. Soiffer, Joseph H Antin, Edwin P. Alyea
Journal: Blood (2016)
Minor Erythroid Response and Decreased WT1 Expression After Proteasome Inhibition by Bortezomib in Myelodysplastic Syndromes (GIMEMA MDS0104 Phase II Trial).
Authors: Massimo Breccia, Roberto Latagliata, Laura Cannella, Ida Carmosino, Enrico Gottardi, Daniela Cilloni, Marco Vignetti, Michelina Santopietro, Marco Mancini, Giuliana Alimena
Journal: Blood (2009)
Inhibition of Nucleocytoplasmic Export Enhances Selective Elimination of Leukemic Stem Cells in Chronic Myeloid Leukemia
Authors: Hein Than, Anthony D. Pomicter, Clinton C. Mason, Anna M. Eiring, William L. Heaton, Dongqing Yan, Anna Senina, Phillip M. Clair, Tessa L. Holyoake, Thomas O'Hare, Michael W. Deininger
Journal: Blood (2017)
Lineage–Specific Chimerism and Incidence of Graft-Failure Following T-Cell Replete Haploidentical Transplantation Using Post-Transplant Cyclophosphamide in Eighty-Nine Consecutive Patients From a Single-Center.
Authors: Amaani Hussain, Connie A. Sizemore, Xu Zhang, Melissa Sanacore, Stacey Brown, Karen Manion, Lawrence E. Morris, H. Kent Holland, Scott R. Solomon, Asad Bashey
Journal: Blood (2012)
Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism (VTE): A Retrospect of Real Life (EXTEND study - updated results)
Authors: Martha L Louzada, Fatimah Al-Ani, Michael J. Kovacs, Lenicio Siqueira, Alejandro Lazo-Langner
Journal: Blood (2015)
Comparison of the ZAP70+ and ZAP70− B-CLL Kinome: Higher Kinase Activity in ZAP70+ B-CLL Cells.
Authors: Miao Wang, Stephano Rosati, Kaushal Parikh, Maikel Peppelenbosch, Simon Daenen, P.M. Kluin, Lydia Visser
Journal: Blood (2006)
Dabigatran Neutralizing Antobody, Idarucizumab, Exhibits Procoagulant and Platelet Activation Responses in Whole Blood. Potential Clinical Implications
Authors: Zafar Siddiqui, Omer Iqbal, Debra Hoppensteadt, Mary Lewis, Rohan Rege, Schuharazad Abro, Jawed Fareed
Journal: Blood (2016)
Impact of Expression of BAALC, CDKN1B, ERG, EVI1, and MN1 on Prognosis and Their Association with Karyotype, FLT3-ITD, NPM1 and MLL-PTD Status In Adult AML: A Comprehensive Study on 286 Cases
Authors: Claudia Haferlach, Alexander Kohlmann, Sonja Schindela, Tamara Alpermann, Wolfgang Kern, Susanne Schnittger, Torsten Haferlach
Journal: Blood (2010)
Humoral Immunity and Plasma Cell Changes in Patients Responding to CD19-Specific Chimeric Antigen Receptor (CAR)-Modified T-Cell Adoptive Immunotherapy
Authors: Vijay Bhoj, Michael C Milone, Carl H. June, David Porter, Stephan A. Grupp, Jan J Melenhorst, Simon F. Lacey, Colleen Callahan, James Capobianchi, Gerald Wertheim, Yolanda Mahnke
Journal: Blood (2014)
MEL1 at 1p36.3 Is Fused to Several Partner Genes Including HOXA9 Located at Different Chromosomal Bands from 3q21.3 in t(1;3)(p36.3;q21.3)-Leukemia.
Authors: Phan Thi Xinh, Hoang Anh, Hideo Tanaka, Shin Fujisawa, Fumitoshi Taketazu, Janet D. Rowley, Katsushi Tokunaga, Yuko Sato
Journal: Blood (2007)
A Transgenic Mouse Assay To Compare the Barrier Activities of the Chicken β-Globin 5′HS4, Human β-Globin 5′HS5 and Mouse 3′HS1.
Authors: Emily E. Devlin, Cheryl Lynn Horton, Lisa J. Garrett-Beal, Patrick G. Gallagher, David M. Bodine
Journal: Blood (2006)
Poor Outcome of RUNX1-Mutated (RUNX1-mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures,
Authors: Jason H. Mendler, Kati Maharry, Michael D. Radmacher, Krzysztof Mrózek, Jessica Kohlschmidt, Deedra Nicolet, Heiko Becker, Klaus H. Metzeler, Sebastian Schwind, Susan P. Whitman, William Blum, Bayard L. Powell, Jonathan E. Kolitz, Thomas H. Carter, Meir Wetzler, Joseph O. Moore, Andrew J. Carroll, Maria R. Baer, Richard A. Larson, Michael A Caligiuri, Guido Marcucci, Clara D. Bloomfield
Journal: Blood (2011)
Loss Of p53 Rescues The Defective Function Of Foxo3-/- Hematopoietic Stem Cells But Enhances Their Predisposition To Malignancy
Authors: Carolina L. Bigarella, Pauline Rimmele, Rebeca Dieguez-Gonzalez, Raymond Liang, Brigitte Izac, Dmitri Papatsenko, Saghi Ghaffari
Journal: Blood (2013)
Third Party Donor Derived CMV Specific T Cells for the Treatment of Refractory CMV Viremia and Disease after Hematopoietic Stem Cell Transplant
Authors: Susan E. Prockop, Aisha Hasan, Guenther Koehne, Ekaterina Doubrovina, Craig S. Sauter, Juliet N, Barker, Karim Baroudy, Farid Boulad, Sergio Giralt, Ramzi Khalaf, Nancy A. Kernan, Esperanza B Papadopoulos, Doris M. Ponce, Andromachi Scaradavou, Stephanie Suser, Gloria Wasilewski, Richard J. O'Reilly
Journal: Blood (2014)
Short-Term Exposure to Arginine Butyrate, in Combination with Ganciclovir, Is as Effective as Continuous Exposure for Virus-Targeted Therapy of EBV-Positive Lymphomas.
Authors: Douglas V Faller, Sajal Ghosh, Tatyana Feldman, Adam Lerner, Judith Smith, Andre Goy, Ronald Berenson, Susan Perrine
Journal: Blood (2009)
Transient but Reversible Activation Defect of T-Cell Responses Against Cytomegalovirus and Adenovirus through Immunosuppresion with Calcineurin Inhibitors.
Authors: Cornelia Neinhaus, Kathrin Opherk, Simone Kayser, Joseph Leibold, Judith Feucht, Peter Lang, Rupert Handgretinger, Tobias F. Feuchtinger
Journal: Blood (2010)
A Prospective Analysis of Erythrocyte Membrane Fatty Acid Concentrations and Risk of Non-Hodgkin Lymphoma
Authors: Brenda M. Birmann, Yu-Han Chiu, Kimberly A. Bertrand, Shumin Zhang, Francine Laden, Mara M. Epstein, Bernard A. Rosner, Edward L. Giovannucci, Jorge E. Chavarro
Journal: Blood (2016)